| Prasertanan, T.; Palmer, D.R.J.; Sanders, D.A.R. (2021). Crystal structure of KabA from Bacillus cereus UW85 in complex with the plp external aldimine adduct with kanosamine-6-phosphate. Protein Data Bank: 7kz5. |
CMCF-ID |
PDB Deposition |
Health |
| Prasertanan, T.; Palmer, D.R.J.; Sanders, D.A.R. (2021). Crystal structure of KabA from Bacillus cereus UW85 with bound cofactor PMP. Protein Data Bank: 7kz6. |
CMCF-ID |
PDB Deposition |
Health |
| Prasertanan, T.; Palmer, D.R.J.; Sanders, D.A.R. (2021). Crystal structure of KabA from Bacillus cereus UW85 in complex with the reduced internal aldimine and with bound Glutarate. Protein Data Bank: 7kzd. |
CMCF-ID |
PDB Deposition |
Health |
| Wang, F.; Cheng, W.; Xu, C.; Qi, J.; Bao, X. et al. (2021). The Crystal Structure of human DHFR from Biortus. Protein Data Bank: 7ese. |
CMCF-ID |
PDB Deposition |
Health |
| Worrall, L.J.; Sun, T.; Mulligan, V.K.; Strynadka, N.C.J. (2021). Structure of NDM-1 in complex with macrocycle inhibitor NDM1i-1G. Protein Data Bank: 6xbf. |
CMCF-ID |
PDB Deposition |
Health |
| Worrall, L.J.; Sun, T.; Mulligan, V.K.; Strynadka, N.C.J. (2021). Structure of NDM-1 in complex with macrocycle inhibitor NDM1i-1F. Protein Data Bank: 6xbe. |
CMCF-ID |
PDB Deposition |
Health |
| Xu, S.; Grochulski, P.; Tanaka, T. (2021). X-ray crystallographic structure model of Lactococcus lactis prolidase mutant D36S. Protein Data Bank: 7n02. |
CMCF-BM |
PDB Deposition |
Health |
| Cathleen M. Crudden; J. Hugh Horton; Mina Raafat Ryad Narouz; Joseph Daniel Padmos (2021). Methods of forming carbene-functionalized composite materials. Patent Number: US11008291B2. |
|
Patent |
|
| Folgueira Judit Anido; Patricia Anne Giblin; Robin Matthew Hallett; Jeanne Magram; Naimish Pandya et al. (2021). COMBINATION OF LIF INHIBITORS AND PLATINUM-BASED ANTI-NEOPLASICS AGENTS FOR USE IN THE TREATMENT OF CANCER. Patent Number: MA52300A. |
|
Patent |
|
| Folgueira Judit Anido; Peter Edward Bayliss; Teixidor Ester Bonfill; Patricia Anne Giblin; Robin Matthew Hallett et al. (2021). PROCEDURES FOR IMPROVING THE RESPONSE TO ANTI-BODY TREATMENT ANTI-LIF IN INDIVIDUALS WITH CANCER. Patent Number: MA52299A. |
|
Patent |
|
| James Philip O'connell; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2021). Mechanism of action. Patent Number: ES2836769T3. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2021). Mechanism of action. Patent Number: US20210140972A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Daniel John Lightwood; Rebecca Jayne MUNRO et al. (2021). Antibody. Patent Number: US20210132079A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Daniel John Lightwood; Rebecca Jayne MUNRO et al. (2021). Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them. Patent Number: US10969393B2. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Tracy Lynn ARAKAKI; Daniel John Lightwood et al. (2021). Antibodies binding to trimeric TNF alpha epitopes. Patent Number: US11022614B2. |
|
Patent |
|